American Academy of Pediatric Dentistry (AAPD). Best Practices: Use of local anesthesia for pediatric dental patients. 2020. Available at: https://www.aapd.org/globalassets/media/policies_guidelines/bp_ localanesthesia.pdf. Accessed on Oct. 25, 2021.
Arrow P. A comparison of articaine 4% and lignocaine 2% in block and infiltration analgesia in children. Aust Dent J. 2012;57:325–33.
de Geus JL, da Costa KN, Wambier LM, et al. Different anesthetics on the efficacy of inferior alveolar nerve block in patients with irreversible pulpitis. JADA 2020;151:87-97.
Dougall AJ, Hayes M, Daly B. A systematic review of the use of local analgesia in medically compromised children and adolescents. Eur Arch Paediatr Dent. 2017;18:331-43.
Kühnisch J, Daubländer M, Klingberg G, Dougall A, et al. Best clinical practice guidance for local analgesia in paediatric dentistry: an EAPD policy document. Eur Arch Paediatr Dent. 2017;18:313-21.
Klingberg G, Ridell K, Brogardh-Roth S, Vall M, Berlin H. Local anesthesia in paediatric dentistry. A systematic review of techniques and pharmacologic agents. Eur Arch Paediatr Dent. 2017. 18:323–9.
Malamed SF. Clinical action of specific agents. In: Handbook of Local Anesthesia. 6th ed. St. Louis, Mo., Mosby; 2020. pp. 57-85.
Monteiro J, Tanday A, Ashley PF, Parekh S, Alamri H. Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment. Cochrane Database Syst Rev. 2020, Article No CD011024.
U.S. Food and Drug Administration (FDA). Risk of serious and potentially fatal blood disorder prompts FDA action on oral over-the-counter benzocaine products used for teething and mouth pain and prescription local anesthetics. May 31, 2018 Available at: https://www.fda.gov/drugs/drug-safety-and-availability/risk-seriousand-potentially-fatal-blood-disorder-prompts-fda-action-oral-over-counter-benzocaine. Accessed May 2, 2020.
Pain in conjunction with dental treatment in children and adolescents should be avoided or minimized. Local anesthesia helps to prevent transmission of pain sensation during procedures which can serve to build trust and foster the relationship of the patient and dentist, alleviate fear and anxiety, and promote a positive dental attitude. Local anaesthetic agents available in dentistry include: articaine, bupivacaine, Background lidocaine, mepivacaine, and prilocaine. Maximum dosage for mepivacaine is 6.6 mg/Kg; prilocaine, 8.0 mg/kg; lidocaine and articaine, 7.0 mg/Kg. The Manufacturer’s Recommended Dose (MRD) maximum dose is for lidocaine is 7.0 mg/kg; however, a long-established dental maximum dose for lidocaine is 4.4 mg/kg.
